The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Type 1 iodothyronine deiodinase in human physiology and disease
Abstract
Thyroid hormone is essential for the normal function of virtually all tissues. The iodothyronine deiodinases catalyze the removal of an iodine residue from the pro-hormone thyroxine (T 4) molecule, thus producing either the active form triiodothyronine (T 3; activation) or inactive metabolites (reverse T 3; inactivation). Type I deiodinase (D1) catalyzes both reactions. Over the last years, several studies have attempted to understand the mechanisms of D1 function, underlying its effects on normal thyroid hormone metabolism and pathological processes. Although peripheral D1-generated T 3 production contributes to a portion of plasma T 3 in euthyroid state, pathologically increased thyroidal D1 activity seems to be the main cause of the elevated T 3 concentrations observed in hyperthyroid patients. On the other hand, D1-deficient mouse models show that, in the absence of D1, inactive and lesser iodothyronines are excreted in feces with the loss of associated iodine, demonstrating the scavenging function for D1 that might be particularly important in an iodine deficiency setting. Polymorphisms in the DIO1 gene have been associated with changes in serum thyroid hormone levels, whereas decreased D1 activity has been reported in the nonthyroid illness syndrome and in several human neoplasias. The current review aims at presenting an updated picture of the recent advances made in the biochemical and molecular properties of D1 as well as its role in human physiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575 · cited 1×
“In starved humans, circulating T3 concentrations decrease rapidly to about 50% of control and remain low for up to 3 weeks of fasting (Vignati et al. 1978, Kaptein et al. 1985, Rosenbaum et al. 2005).”
Légrádi, G., Emerson, C. H., Ahima, R. S., Flier, J. S., & Lechan, R. M. (1997) · Endocrinology · doi:10.1210/en.138.6.2569 · Cited by 505
Peeters, R. P., Wouters, P. J., Kaptein, E., van Toor, H., Visser, T. J., & Van den Berghe, G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022013 · Cited by 452
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans
Luiza Maia, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25083 · Cited by 360 · cited 6×
“…209, 283–297 Downloaded from Bioscientifica.com at 12/13/2018 03:53:49AM via free access liver and kidney D1 increases in the presence of excessive thyroid hormone levels, this enzyme is also responsible for the majority of the peripheral T3 production (Maia et al. 2005, Laurberg et al. 2007).”
InfluentialThe Deiodinase Family of Selenoproteins
GERMAIN, D. L. S., & GALTON, V. A. (1997) · Thyroid · doi:10.1089/thy.1997.7.655 · Cited by 342
Nakamura, H., Noh, J. Y., Itoh, K., Fukata, S., Miyauchi, A., Hamada, N., & Working Group of the Japan Thyroid Association for the Guideline of the Treatment of Graves’ Disease (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2135 · Cited by 277 · cited 2×
“Nevertheless, methimazole is superior to PTU during chronic therapy (Nakamura et al. 2007).”
Schneider, M. J., Fiering, S. N., Thai, B., Wu, S.-Y., St. Germain, E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2006) · Endocrinology · doi:10.1210/en.2005-0739 · Cited by 265 · cited 7×
“However, the rate of disappearance of T3 was comparable in euthyroid WTand D1KO mice (Schneider et al. 2006).”
InfluentialPeeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251 · cited 3×
“An entire set of data obtained from critically ill patients demonstrated that patients with more pronounced alterations in serum thyroid parameters have a significantly higher mortality rate and that rT3 and T3/rT3 are prognostic factors for survival (Peeters et al. 2005c).”
Type 2 iodothyronine deiodinase is highly expressed in human thyroid.
Salvatore, D., Tu, H., Harney, J. W., & Larsen, P. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118880 · Cited by 196
Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness.
Boelen, A., Platvoet-Ter Schiphorst, M. C., & Wiersinga, W. M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263160 · Cited by 196
Geffner, D. L., Azukizawa, M., & Hershman, J. M. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107925 · Cited by 192 · cited 10×
“Moreover, the relatively low doses of PTU used in chronic therapy will not effectively inhibit D1.”
InfluentialJøRGENSEN, J. O. L., PEDERSEN, S. A., LAURBERG, P., WEEKE, J., SKAKKEBÆK, N. E., & CHRISTIANSEN, J. S. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1127 · Cited by 192
Galton, V. A., Schneider, M. J., Clark, A. S., & St. Germain, D. L. (2009) · Endocrinology · doi:10.1210/en.2008-1572 · Cited by 181
Gereben, B., Goncalves, C., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0558 · Cited by 161
Abuid, J., & Larsen, P. R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107744 · Cited by 156 · cited 1×
“In agreement with earlier studies (Abuid & Larsen 1974), it was observed that patients treated only with PTU, a specific inhibitor of D1, presented a rapid and sustained fall in serum T3 levels of w57%, whereas those treated with a combination of PTU plus potassium iodine or sodium ipodate, which…”
Panicker, V., Cluett, C., Shields, B., Murray, A., Parnell, K. S., Perry, J. R. B., Weedon, M. N., Singleton, A., Hernandez, D., Evans, J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0397 · Cited by 155
Tissue Thyroid Hormone Levels in Critical Illness
Peeters, R. P., van der Geyten, S., Wouters, P. J., Darras, V. M., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1013 · Cited by 145
Toyoda, N., Zavacki, A. M., Maia, A. L., Harney, J. W., & Larsen, P. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5100 · Cited by 142
Self-citationReduction in extrathyroidal triiodothyronine production by propylthiouracil in man.
Saberi, M., Sterling, F. H., & Utiger, R. D. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107924 · Cited by 138 · cited 1×
“Moreover, clinical studies have showed a maximum decrease of 25% in serum T3 in athyreotic, T4replaced, euthyroid individuals treated with higher doses of PTU (Geffner et al. 1975, Saberi et al. 1975).”
Rodriguez‐Perez, A., Palos‐Paz, F., Kaptein, E., Visser, T. J., Dominguez‐Gerpe, L., Alvarez‐Escudero, J., & Lado‐Abeal, J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03102.x · Cited by 110 · cited 2×
“In contrast, other studies found no differences in D1 activity measured in the subcutaneous adipose tissue in patients in intensive care units, suggesting that thyroid hormone bioavailability might be regulated in a tissue-specific way (Rodriguez-Perez et al. 2008).”
Boelen, A., Maas, M. A., Lowik, C. W., Platvoet, M. C., & Wiersinga, W. M. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940342 · Cited by 108
A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
Peeters, R. P., van der Deure, W. M., & Visser, T. J. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02279 · Cited by 107 · cited 1×
“In contrast, however, several genetic variations have been described in DIO1 and DIO2 genes, which may influence circulating or intracellular thyroid hormone levels (Peeters et al. 2006, Butler et al. 2010, Dora et al. 2010).”
Torpy, D. J., Tsigos, C., Lotsikas, A. J., Defensor, R., Chrousos, G. P., & Papanicolaou, D. A. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90338-9 · Cited by 95
Yu, J., & Koenig, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004866200 · Cited by 94
Regulation of Type 1 Iodothyronine Deiodinase in Health and Disease
Koenig, R. J. (2005) · Thyroid · doi:10.1089/thy.2005.15.835 · Cited by 90
Kim, S.-W., Harney, J. W., & Larsen, P. R. (1998) · Endocrinology · doi:10.1210/endo.139.12.6334 · Cited by 86 · cited 1×
“Because DIO1 expression is positively regulated by thyroid hormone, D1-catalyzed T4 to T3 reaction is expected to be decreased in the hypothyroid state (Maia et al. 1995c, Kim et al. 1998).”
LoPresti, J. S., Eigen, A., Kaptein, E., Anderson, K. P., Spencer, C. A., & Nicoloff, J. T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114343 · Cited by 80 · cited 1×
“On the other hand, the administration of dexamethasone to euthyroid adult males increased the circulating rT3 and rT3/T4 ratios, which could be a result of the augmented production of rT3 instead of decreased clearance (LoPresti et al. 1989).”
Rapid and selective inner ring deiodination of thyroxine sulfate by rat-liver deiodinase
MOL, J. A., & VISSER, T. J. (1985) · Endocrinology · doi:10.1210/endo-117-1-8 · Cited by 76 · cited 1×
“Conjugation of the phenolic hydroxyl with sulfate markedly enhances the suitability of the iodothyronine substrates for D1-catalyzed 5 0 deiodination (Otten et al. 1983, Mol & Visser 1985).”
Zhang, C.-Y., Kim, S., Harney, J. W., & Larsen, P. R. (1998) · Endocrinology · doi:10.1210/endo.139.3.5849 · Cited by 72
Regulation of Tissue Iodothyronine Deiodinase Activity in a Model of Prolonged Critical Illness
Debaveye, Y., Ellger, B., Mebis, L., Darras, V. M., & Van den Berghe, G. (2008) · Thyroid · doi:10.1089/thy.2007.0287 · Cited by 50
Skeletal muscle deiodinase type 2 regulation during illness in mice
Kwakkel, J., van Beeren, H. C., Ackermans, M. T., Platvoet-ter Schiphorst, M. C., Fliers, E., Wiersinga, W. M., & Boelen, A. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0118 · Cited by 48 · cited 1×
“Changes in deiodinases expression have been postulated to play important roles in the altered circulating levels of thyroid hormones in fasting and nonthyroidal illness syndrome (NTIS) (Debaveye et al. 2008, Kwakkel et al. 2009).”
Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice
Yu, J., & Koenig, R. J. (2006) · Endocrinology · doi:10.1210/en.2005-1443 · Cited by 46
Beech, S. G., Walker, S. W., Arthur, J. R., Lee, D., & Beckett, G. J. (1995) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0140171 · Cited by 28 · cited 1×
“The effect of selenium deficiency on the Journal of Endocrinology (2011) 209, 283–297 synthesis of intracellular selenoproteins is apparently tissue dependent, being more pronounced in liver, skeletal muscle, and heart (Meinhold et al. 1992, Bermano et al. 1995, Bates et al. 2000).”
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Scientific Opinion on Dietary Reference Values for iodine
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3660 · Cited by 266
Iodothyronine deiodinase structure and function: from ascidians to humans
Darras, V. M., & Van Herck, S. L. J. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0204 · Cited by 162
“As such, it functions as a scavenger enzyme to remove inactive iodothyronines and recycle iodine within the organism (Bianco et al. 2002, St Germain et al. 2009, Maia et al. 2011).”
BackgroundTSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Metadata
- Authors
- Maia, A. L., Goemann, I. M., Meyer, E. L. S., & Wajner, S. M.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2011-03-17
- Volume
- 209
- Issue
- 3
- Pages
- 283-297
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2071596157
- Cited by
- 222
- References
- 37
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.